Tillou X, Boutemy F, Remond A, Petit J
Service d'urologie-transplantation, CHU Sud, avenue Laennec, 80054 Amiens, France.
Prog Urol. 2010 Oct;20(9):627-32. doi: 10.1016/j.purol.2010.02.009. Epub 2010 Aug 26.
The purpose of this study was to present the role of embolization in the treatment of kidney angiomyolipomas (AML), for preventive care or in case of bleeding.
From March 1995 to March 2007, 22 AML in 21 patients (16 women and five men, mean age 38 years) were embolized: five AML were treated for hemorrhagic shock emergency and 16 were preventive embolization. Eight AML were discovered incidentally and nine patients had pain or hematuria. The average size of AML was 70 mm (20 to 130 mm). The embolization was performed with coils or embospheres.
Three patients have not been embolized because of renal failure catheterization. The embolization was effective in 100% of patients treated in emergency. The six patients cared for gross hematuria and pain were asymptomatic after embolization. The average tumor size reduction was 32% with a mean time of 53.2 months (five to 101 months). Three patients (14%) have benefited from surgery remotely.
Embolization is the best technique for treating bleeding secondary to AML. In preventive treatment or symptomatic, AML embolization is a treatment to offer before considering surgery.
本研究旨在阐述栓塞术在肾血管平滑肌脂肪瘤(AML)治疗中,对于预防性治疗或出血情况的作用。
1995年3月至2007年3月,对21例患者(16例女性和5例男性,平均年龄38岁)的22个AML进行了栓塞治疗:5个AML因出血性休克急症接受治疗,16个为预防性栓塞。8个AML为偶然发现,9例患者有疼痛或血尿症状。AML的平均大小为70毫米(20至130毫米)。栓塞术采用弹簧圈或栓塞球进行。
3例患者因肾衰竭插管未进行栓塞。栓塞术对所有急症治疗患者均有效。6例因肉眼血尿和疼痛接受治疗的患者栓塞后无症状。平均肿瘤大小缩小32%,平均时间为53.2个月(5至101个月)。3例患者(14%)后来接受了手术。
栓塞术是治疗AML继发出血的最佳技术。在预防性治疗或有症状时,AML栓塞术是在考虑手术之前应采用的一种治疗方法。